Related Experiment Video
Updated: May 5, 2026

Rat Model of the Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy ALPPS Procedure
Published on: August 14, 2017
Risk factors and predictive modeling of early postoperative liver function abnormalities.
Lin Zhong1, Hao-Yuan Wang1, Xiao-Na Li2
1Second Clinical Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510120, Guangdong Province, China.
Preoperative elevated liver enzymes, low platelets, and sevoflurane use are key risk factors for postoperative liver dysfunction. A new model effectively predicts this liver injury risk across various surgeries.
Area of Science:
- Anesthesiology and Perioperative Medicine
- Hepatology
- Surgical Outcomes Research
Background:
- Limited research exists on factors influencing postoperative abnormal liver function in non-hepatic and non-cardiac surgeries.
- Understanding these factors is crucial for improving patient outcomes and developing targeted interventions.
Purpose of the Study:
- To identify risk factors for early postoperative abnormal liver function across diverse surgical types.
- To develop and validate a predictive model for postoperative liver dysfunction.
Main Methods:
- Retrospective cohort study of 3720 patients from 5 surgical departments.
- Logistic regression and LASSO analysis identified risk factors; a prediction model was constructed.
- Model performance was assessed using the Hosmer-Lemeshow test and ROC curve analysis.
Main Results:
- Key predictors of abnormal liver function include elevated preoperative aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels, and reduced platelet counts.
- Intraoperative sevoflurane use was also identified as a significant risk factor.
- The developed prediction model showed strong predictive efficacy and good calibration.
Conclusions:
- Elevated preoperative liver enzymes, low platelet counts, and sevoflurane use are significant risk factors for postoperative liver injury.
- The established risk prediction model demonstrates robust efficacy in identifying patients at risk for liver dysfunction.
Related Concept Videos
Hepatic Drug Excretion: Influencing Factors
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Drug Toxicity: Risk factors

